ADM Ventures, the corporate venture capital arm of ADM (NYSE: ADM), invested in Seventure’s Health For Life Capital (HFLC) Fund II.
HFLC, based in Paris, is a venture capital fund dedicated to health, nutrition, microbiota and digital health.
The microbiome consists of trillions of micro-organisms that reside on or inside the human body. ADM’s primary interest is the vast, complex bacterial ecosystem that lives within the digestive tract and constitutes the majority of every individual’s unique microbiome.
ADM is committed to discovering and leveraging nutritional ingredients that can be used for preventative health, as well as for treating common ailments or even chronic diseases in both humans and animals. The company’s new probiotics production facility in Valencia, Spain – which will significantly increase its post- and prebiotic production capacity – is planned to be online in 2022.